STANDEX Form 4: 11,000-Share Sale by CEO Executed via 10b5-1 Plan
Rhea-AI Filing Summary
Standex International Corp reporting person David A. Dunbar, who is listed as President/CEO/Chairman and Director, sold shares under an existing trading plan. The filing shows a sale of 11,000 shares of common stock on 09/18/2025 at a price of $215 per share, executed pursuant to a 10b5-1 plan dated November 22, 2024. After the reported transaction, the reporting person is shown as beneficially owning 121,973 shares indirectly. The form also references 1,429.9759 shares in connection with a trustee relationship. The form is signed by Alan J. Glass on 09/19/2025.
Positive
- Sale executed under a documented 10b5-1 trading plan, which typically reduces signaling risk associated with insider sales
Negative
- Insider disposition of 11,000 shares by the President/CEO/Chairman, which represents insider selling activity
- Limited detail on the indirect ownership structure; the filing references 1,429.9759 shares tied to a trustee but gives no explanatory context
Insights
TL;DR: Routine insider sale under a pre-existing 10b5-1 plan; notable because it comes from the company CEO/Chair.
The filing documents a disposition of 11,000 common shares at $215 each on 09/18/2025 executed under a 10b5-1 trading plan dated 11/22/2024. Such plan-based sales generally indicate pre-authorized liquidity rather than opportunistic trading. The report shows 121,973 shares beneficially owned post-transaction on an indirect basis, and lists 1,429.9759 shares tied to a trustee capacity. For investors, this is a disclosure of insider selling from a senior officer but is described as plan-driven, reducing immediate interpretive weight. The filing is factual and contains no additional financial metrics.
TL;DR: Disclosure aligns with best practices; sale executed under documented 10b5-1 plan and properly reported.
The Form 4 indicates compliance with Section 16 reporting: transaction date, amount, price, and statement that the sale was pursuant to a 10b5-1 plan (11/22/2024). The reporting person is identified with officer and director roles, and the signature block is present with a 09/19/2025 signature. The form notes indirect beneficial ownership and a trustee reference but does not provide further detail on beneficial ownership structure. From a governance perspective the filing appears complete for the disclosed transaction.